The RPS6 gene encodes Ribosomal Protein S6, a core component of the 40S small ribosomal subunit that plays a critical role in protein synthesis and cell growth regulation. RPS6 is uniquely notable as the major physiological substrate of ribosomal protein S6 kinases (RSK1-4 and S6K1-2), linking it directly to the mTOR signaling pathway. Mutations in RPS6 are associated with Noonan syndrome and other RASopathies, as well as Diamond-Blackfan anemia, making it an important gene in both developmental disorders and cancer biology.
| Full Name | Ribosomal Protein S6 |
|---|---|
| Gene Symbol | RPS6 |
| Chromosomal Location | 9p21.1 |
| NCBI Gene ID | [6196](https://www.ncbi.nlm.nih.gov/gene/6196) |
| OMIM | [180460](https://www.omim.org/entry/180460) |
| Ensembl ID | [ENSG00000143977](https://www.ensembl.org/Homo_sapiens/ENSG00000143977) |
| UniProt ID | [P62753](https://www.uniprot.org/uniprot/P62753) |
| Protein Length | 249 amino acids |
| Protein Molecular Weight | ~28.7 kDa |
| Associated Diseases | [Noonan Syndrome](/diseases/noonan-syndrome), [Cancer](/diseases/cancer), [Diamond-Blackfan Anemia](/diseases/diamond-blackfan-anemia) |
The RPS6 gene is located on chromosome 9p21.1 and encodes a protein of 249 amino acids. RPS6 is highly conserved across eukaryotes, from yeast to humans, reflecting its essential role in cellular function.
RPS6 is a member of the ribosomal protein S6 family. The protein contains:
RPS6 is one of the most studied ribosomal proteins due to its role in the mTOR pathway. Its conservation across species reflects:
RPS6 is an essential component of the 40S ribosomal subunit:
Ribosome Assembly: RPS6 is required for proper 40S subunit assembly and ribosome biogenesis
Translation Initiation: RPS6 interacts with translation initiation factors, facilitating the formation of the pre-initiation complex
mRNA Binding: RPS6 contributes to mRNA binding and the scanning process
Translation of Specific mRNAs: RPS6 phosphorylation specifically enhances translation of 5'TOP (terminal oligopyrimidine) mRNAs encoding ribosomal proteins and translation factors
RPS6 serves as a critical downstream target of the mTOR (mammalian Target of Rapamycin) pathway:
The phosphorylation of RPS6 is a key readout of mTORC1 activity and is widely used as a biomarker for mTOR pathway activation [1].
RPS6 is phosphorylated at multiple sites:
These phosphorylation events:
RPS6 is ubiquitously expressed, with highest expression in:
In the brain, RPS6 is expressed in neurons and glial cells. Its phosphorylation state is particularly important in synaptic plasticity and memory formation.
Noonan syndrome is a genetic disorder characterized by:
RPS6 mutations were identified as a cause of Noonan syndrome, making it one of the several genes in the RASopathies spectrum [2].
Pathogenic Mechanisms:
RPS6 is frequently activated in cancers:
While less common than other ribosomal protein genes, RPS6 mutations have been identified in DBA:
Ribosomal dysfunction is increasingly recognized in neurodegenerative diseases:
The mTORC1-RPS6 pathway integrates cellular signals:
RPS6 phosphorylation regulates:
The mTOR-RPS6 pathway has complex roles in neurodegeneration:
The mTOR-RPS6 pathway is a major therapeutic target:
Treatment approaches for RPS6-related RASopathies:
Modulating the RPS6 pathway in neurodegeneration:
Key areas for future investigation:
RPS6 and mTOR signaling. Trends Cell Biol. 2021. ↩︎
RPS6 mutations in RASopathies. Nat Rev Cancer. 2020. ↩︎